chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 24 hours of receiving the vaccine, I had the expected side effects - fever, chills, achiness, headache, nausea. The following day, these symptoms all resolved, but I felt what I can only explain as "manic" - very high energy, poor ability to concentrate, people around me that day commented that I was "very talkative."  This lasted for about 12-18 hours. One week after the vaccine, I experienced an irregular menstrual period - very light, on and off spotting for several days. No treatment was sought for any of these symptoms.
On day 1 I had a low fever. On day 2-3, I had digestive unrest On day 10, the "Moderna Rash" appeared with a lump that was red, hot and itchy. This lasted 6 days. On Day 11, my lips and throat became swollen and tingly with my throat becoming enflamed. This lasted 3 days and was partially soothed by taking Claritin.
I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 2/8/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  SARS-COV-2 VACCINE REFUSAL---N/A
This spontaneous report as received from a registered nurse refers to an about 22 years old female patient. The patient was vaccinated with dose 3 GARDASIL (Lot # not reported). No other co-suspects were reported. No concomitant medications were reported. The nurse reported that the patient, a friend of her daughter, recently got all 3 doses of GARDASIL and on 11-JUL-2012, "about a week ago", was diagnosed with human papilloma virus infection. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Janssen COVID-19 Vaccine EUA Symptoms started around 5:30 PM with muscle aches in all limbs. Between 6 and 6:30 chills started. Went to bed at 7 PM with waves of chills happening every few minutes. This continued for a few hours, then had fever. Next morning muscle aches were still present and lasted throughout the day. Muscle aches are mostly gone today, Thursday, 12/2/2021.
Slowly building fever over 2 days. High fever was 101.5 F along with moderate to severe pain at the injection site.
received shot 0935a, 0940a patient started to feel lightheaded, hot, sweating; reports hx of this with anxiety and needle anxiety. brought back to obs, offered apple juice and water, laying down, patient feels some relief. 0945: bp 139/82 rr 20 hr 71 sats 95% on ra. feeling better per patient. 0950: bp 138/88 hr 77 rr 20 sats 98% on ra. 1000: bp 137/85 hr 71 rr 20 sats 97% on ra sitting up. patient states feeling back to baseline, s/s resolved. escorted with s/o to private vehicle.
INTENSE MIGRAINES, ABDOMINAL PAIN, LIGHT HEADED, SHORTNESS OF BREATH WHEN I WALK.
Case number PHEH2011US05758 is an initial spontaneous report received from a physician on 29 Sep 2011. This case refers to four patients. These four patients inadvertently received only the MenCWY component of MENVEO (batch number: unknown) instead of being reconstituted with MenA, intramuscularly on unspecified date. No adverse reaction had occurred following this drug administration error.
miscarriage; have had long and inconsistent cycles since vaccination; This is a spontaneous report received from contactable reporter(s) (Consumer or other non healthcare professional). The reporter is the patient.  A 37 year-old female patient (pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 17Jun2021 14:00 (Lot number: EW0168) at the age of 37 years as DOSE 2, SINGLE for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). Date of last menstrual period: 18May2021. The patient was 4 weeks pregnant at the time of exposure to bnt162b2. The patient was 4 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 22Feb2022. The patient had no covid vaccine within 4 weeks and has not been tested post vaccination. Concomitant medication(s) included: ESCITALOPRAM; ZYRTEC. Past drug history included: Neomycin, reaction(s): "Known allergies: Neomycin"; Erythromycin, reaction(s): "Known allergies: Erythromycin"; Fluorescein, reaction(s): "Known allergies: Fluorescein". Vaccination history included: Bnt162b2 (Dose Number: 1, Lot No: EW0172, Location of injection: Arm Left, Vaccine Administration Time: 12:30 PM), administration date: 27May2021, when the patient was 37 years old, for COVID-19 Immunization, reaction(s): "Exposure during pregnancy (Patient last menstrual period date :18May2021)". The following information was reported: ABORTION SPONTANEOUS (medically significant) with onset 19Jun2021, outcome "recovered with sequelae" (2021), described as "miscarriage"; MENSTRUAL DISORDER (non-serious) with onset 2021, outcome "unknown", described as "have had long and inconsistent cycles since vaccination". The event "miscarriage" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: blood test: (2021) unknown, notes: confirmed that no hcg levels remained. Therapeutic measure Rhogam injection was taken as a result of abortion spontaneous (loss of pregnancy).; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101691653 same patient, different dose, different event;US-PFIZER INC-202101691654 same patient, different drug, different event
Swelling and redness in vaccine area. 8/21 - received vaccine. 8/22 - swelling and welting Kw/ redness. 8/23 Si/sx include dark.
This spontaneous report was received from a pharmacy administrator via a company representative referring to an 85 year old male patient. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. In approximately 2014 (reported as about 3 years ago), the patient was vaccinated with a dose of ZOSTAVAX for prevention of shingles (dose, route, lot # and expiration date were not reported). It was stated that the patient had recurrent episodes of shingles on his foot since receiving the ZOSTAVAX injection. It was also reported that the patient sought his primary provider and he was treated with VALTREX for the adverse event. The reporter stated that, they felt this was a "weird situation". At the time of reporting the outcome of the event was unknown. A product quality complaint was not involved. The causality assessment between the adverse event and ZOSTAVAX was not provided. Additional information has been requested.
Pt started developing fever (104 degree F) 1 day after vaccine administration. Pt also developed papular rash on extremities 5 days after vaccine administration. Pt presented to doctor's office on 8/1/17 with multiple papules on upper and lower extremities and nasal congestion.
m.d. rpt that a pt vax on 22aug98  exp  ``measles-like rash'' on 01sep98. pt sought med attention. m.d. felt rash not related to therapy w/mmr
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concomitant medications and drug allergies were not reported. On an unknown date, the patient was vaccinated with PROQUAD therapy type rHA, lot # N013865, expiration date 31-OCT-2018. On an unknown date (five days after the first dose), the patient inadvertently received an additional dose of PROQUAD therapy type rHA, lot # N013865, expiration date 31-OCT-2018. The vaccines were reconstituted with sterile diluent. No adverse effects were reported.
Area red and swollen, feverish, non-stop screaming. Taken to ER, given Tylenol with codeine and Benadryl.
Information has been received from a nurse concerning a female who was vaccinated with the second dose of GARDASIL 0.5ml, and experienced some chest pain and some symptoms.  In June 2008, the patient was vaccinated with the third dose of GARDASIL 0.5ml . After receiving the third dose, in approximately June 2008 the patient developed chest pain, headache, sharp pain behind her right ear and numbness and tingling on her head. A chest X-ray and CAT scan were performed but the results came back normal. The patient sought unspecified medical attention. Additional information has been requested.
This spontaneous report was received from a pharmacist via Pfizer (manufacturer control number# 2018100629) regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On unknown date, the patient started therapy with VAQTA (route, frequency, lot#, expiration date unknown) for prophylaxis. On an unknown date, the patient had received the other products (VAQTA) after the same temperature excursion (product storage error). No adverse effect reported.
Fatigue Narrative: Pt is a 66 year old male with PMH significant for paranoid schizophrenia, aortic stenosis s/p TAVR 2015 admitted to short-stay rehab post- hospital stay 12/7-12/10 for falls and gait instability. Pt received COVID-19 vaccine 12/17/20. Pt refused physical therapy 12/18/20 d/t fatigue and also expressed being "too tired" during occupational therapy visit 12/18/20. No further reports of fatigue after these events.
Info has been received from a physician concerning a 12 year old pt who in 2001 or 2002 was vaccinated with a dose of varicella virus vaccine live. In 11/05, the pt developed a case of breakthrough case of chickenpox. The pt had bumps on the body. Unspecified medical attention was sought. A product quality complaint was not involved. Additional info has been requested. It was also noted that the pt's 10 year old sibling had a similar reaction after vaccination received from a different lot number.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Dec2021 at 13:00 as dose 3 (booster), single at the age of 53 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "pre diabetic" (unspecified if ongoing); "eat GF diet" (unspecified if ongoing), notes: eat GF diet due to food intolerances & barley allergy; "barley allergy" (unspecified if ongoing), notes: eat GF diet due to food intolerances & barley allergy; "known allergies: shellfish" (unspecified if ongoing); "known allergies: oregano, Paprika" (unspecified if ongoing); "food intolerances" (unspecified if ongoing), notes: eat GF diet due to food intolerances & barley allergy. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162B2 has been requested and will be submitted if and when received.
Shortness of breath; Weakness; Loss of appetite; Headache; Fever;temp was elevated; Chills; Body pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), ASTHENIA (Weakness), DECREASED APPETITE (Loss of appetite), HEADACHE (Headache) and PYREXIA (Fever;temp was elevated) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Anxiety, Irritable bowel syndrome and Thyroid disorder. Concomitant products included ALPRAZOLAM (XANAX) for Anxiety, LEVOTHYROXINE for Thyroid disorder NOS.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath), ASTHENIA (Weakness), DECREASED APPETITE (Loss of appetite), HEADACHE (Headache), PYREXIA (Fever;temp was elevated), CHILLS (Chills) and MYALGIA (Body pain). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Adverse event, at a dose of 1 dosage form. At the time of the report, DYSPNOEA (Shortness of breath), ASTHENIA (Weakness), DECREASED APPETITE (Loss of appetite), HEADACHE (Headache), PYREXIA (Fever;temp was elevated), CHILLS (Chills) and MYALGIA (Body pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, Body temperature: High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also included high blood pressure medications, antidepressants, IBS medications and digestive enzyme with water.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: TCR: Follow-up received on 22-6-21 doesn't contain any new information.
Headache arm pain, body aches (unspecified), fatigue Narrative:  Other Relevant History:
I did not have an adverse reaction to the vaccine.  I tested positive for COVID-19 in 02/2023.  I contacted my doctor and got a prescription. I developed a skin infection in 02/2023 and in 03/2023 and I went to the doctor and got a topical prescription and antibiotics. I also got a steroid injection. As of today, I have no lingering symptoms.
About 4-6 hours after I had the vaccine, I experienced severe tenderness at the injection site. I had a low grade fever of 99.6 for a short period of time. Dizziness, headache, and body aches have continued over the past 9 hours (~2AM - 11:30AM).
approx 4yrs p/vax pt exp a case of breakthrough varicella w/under 50 lesions & generalized rash
Pt had 102 Fever with joint aches, nausea and headache severe enough to keep him in bed for 3-4 days
had Covid twice once before the Covid-19 vaccines and once after; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (had Covid twice once before the Covid-19 vaccines and once after) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Patient has severe medical conditions.  The patient's past medical history included COVID-19 (had COVID once before vaccine).    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (had Covid twice once before the Covid-19 vaccines and once after). At the time of the report, COVID-19 (had Covid twice once before the Covid-19 vaccines and once after) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant drugs were not reported.  Treatment medications were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-676674 (E2B Linked Report). This case was linked to MOD-2022-676617 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-676674:Cluster case for a lot of false positives in people
Chills, severe aches in eyes, cheek bones, teeth, hands, feet, dizziness, weakness, gas, fatigue
I am experiencing the worst oral herpes outbreak I have had in many years. I have about 4 blisters -- I don't think I've had this many since I first got the infection at about age 12. My eyelid is also feeling sore. I am worried that I am actually getting an ocular herpes infection.
Injected an expired dose of the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Injected an expired dose of the vaccine) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Injected an expired dose of the vaccine). On 20-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Injected an expired dose of the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 045A21A)  with no associated AEs.; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 045A21A)  with no associated AEs.
The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609,expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 03-APR-2021, the subject experienced body aches. On 03-APR-2021, the subject experienced arm pain. On 03-APR-2021, the subject experienced chills. On 03-APR-2021, the subject experienced general unwell. On 03-APR-2021, the subject experienced fever 101 F. On 03-APR-2021, the subject experienced headaches. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, general unwell, fever 101f, and headaches on 04-APR-2021, and arm pain on 03-APR-2021. This report was non-serious.
parents state screamed & cried p/leaving office, would fall asleep then awaken screaming;this went on x5-6 days;would not eat more than bottle q d, 5-6oz;fussy;would not be consoled;T101 next day only;
headache; like she hit a wall.; her hand it hurts; joint paint in her R hand; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (like she hit a wall.), PAIN IN EXTREMITY (her hand it hurts), ARTHRALGIA (joint paint in her R hand) and HEADACHE (headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced FEELING ABNORMAL (like she hit a wall.), PAIN IN EXTREMITY (her hand it hurts) and ARTHRALGIA (joint paint in her R hand). On 22-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (like she hit a wall.), PAIN IN EXTREMITY (her hand it hurts) and ARTHRALGIA (joint paint in her R hand) outcome was unknown and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       . Concomitant medications reported were to treat high blood pressure.
On February 4, 2023, in mile five or six of my run, I started to feel lightheaded. I didn't feel dizzy, but it felt different. It lasted a few seconds. I was able to continue running, but I turned around to go back. It happened again on the same run. The second time it lasted a few seconds, but I felt nauseous as well. Since that day, I have the lightheadedness every run. I usually run four to five time a week. I run less now because the symptoms seem to last longer, and the nausea comes with it. I've also noticed that it happens when I walk as well. I just don't feel right. I have had vertigo in the past, but it doesn't feel the same. My brain feels like it shifts. It feels like something happens to my equilibrium. I make sure I'm hydrated, and it still happens. I've tried different things, but it just keeps happening. At times, it will happen when I'm not exercising. It won't be as bad as when I'm exercising. I went to the doctor on March 10, 2023. I had a Physical. She also gave me an EKG. It was normal. On March 15, 2023, a Cardiologist gave me a Treadmill Test. It was normal. The next thing she recommended was an appointment with a Neurologist. I'm working on scheduling it. I'm a long-time runner for years, and I've never had this experience. I'm used to running long distances, marathons, and ultramarathons.
Pt. received 0.5 mL FLUVIRIN. Pt. works for pharmacy where administered. Pt. returned to pharmacy 5 mins after administration complaining of localized hives/itching. Gave 50 mg diphenhydramine. Over next 3-4 minutes itching spread all over body. Injected 0.3 mg epinephrine and pt. recovered completely.
Pt was to receive only flucelvax vaccine, however, was accidently administered moderna bivalent booster as well.  Pt stayed for 15 minutes and did not have any reaction.  Pt stated they were okay to return home.  Pt will be followed up with in 24 hours.
Vomiting, nausea, severe headache, chills, fever to 100.4, body aches and fatigue
This spontaneous report as received from a Medical Assistant refers to a 8 year old male patient. On 20-SEP-2014 the patient was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date not reported). There was no concomitant medication reported. No adverse effects were reported. Additional information has been requested.
chills, fever (highest 102.8), body aches onset around 1am (approx 16 hrs after receiving dose); woke up around 5am and fever had come down; by the time I awoke again at 11am I felt very tired but all other symptoms had resolved
4/2 -2am - freezing cold, ache in muscles & bones:  4/2-6am fever 100.4 until 3pm - then 98.4 and by 8am following day - back to normal for me- 97.5. Headache.  Aches in muscles and bones.  exhausted.  afternoon nap - &  Slept 10 hrs  night April 2nd;
This is a spontaneous report from a Pfizer-sponsored program, IBCC (Inbound Call Center for HCPs), received from a contactable pharmacist. A 78-year-old female patient received PREVNAR 13 (lot number: R12280, expiry date: 28Feb2018), via an unspecified route of administration on 12Aug2017 approximately 16:10 at single dose so the patient does not get pneumonia. The patient's medical history and concomitant medications were not reported. On an unspecified date in Aug2017, the patient reported redness and a little bit of swelling in the arm that was injected. It was reported that it goes from the injection site and then it spreads down to about half way of her lower left arm. The patient has been using hydrocortisone on it as there was some slight itching and swelling. The patient was also advised to use ice packs. The patient further reported that it has been increasing in size/ growing each day. The outcome of the events was not recovered. The reporter assessed the events 'redness and a little bit of swelling in the arm that was injected' as related to the suspect vaccine.
Information has been received from a nurse practitioner refrring to a patient of unknown age and gender. On 18-FEB-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 32 (lot # L014420 with expiration date of 23-FEB-2017; strength, dosage and frequency unspecified) (Incorrect product storage). No adverse effect was reported. Additional information has been requested.
3 days after vaccines, pt. developed urticaria on his trunk, upper and lower extremities. He was seen at a local ER, and was given prednisolone once daily for 5 days and BENADRYL every 6 hours.